ACTH-independent macronodular adrenal hyperplasia

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 23, Issue 2, 2009, Pages 245-259

  Lacroix, André ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

aberrant adrenal G protein coupled receptors; ACTH independent macronodular adrenal hyperplasia (AIMAH); Cushing's syndrome; familial forms

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ARGIPRESSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CHORIONIC GONADOTROPIN; CORTICOTROPIN; CORTICOTROPIN RECEPTOR; DESMOPRESSIN; DEXAMETHASONE; G PROTEIN COUPLED RECEPTOR; GASTROINTESTINAL POLYPEPTIDE; GLUCAGON; GONADORELIN; GONADORELIN AGONIST; ISOPRENALINE; LEUPRORELIN; LUTEINIZING HORMONE; METOCLOPRAMIDE; MINERALOCORTICOID; OCTREOTIDE; PROTIRELIN; SEROTONIN; SEROTONIN ANTAGONIST; SEX HORMONE; TETRACOSACTIDE; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST;

ADENOMATOUS POLYP; ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADRENALECTOMY; AGE DISTRIBUTION; AUTOSOMAL DOMINANT INHERITANCE; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; FAMILY HISTORY; HUMAN; HYDROCORTISONE RELEASE; INCIDENTAL FINDING; LAPAROSCOPIC SURGERY; MULTIPLE ENDOCRINE NEOPLASIA; PARACRINE SIGNALING; PATHOPHYSIOLOGY; REVIEW; SEX RATIO; STEROIDOGENESIS;

ADRENAL CORTEX HORMONES; ADRENAL HYPERPLASIA, CONGENITAL; ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; ANIMALS; HUMANS; PITUITARY ACTH HYPERSECRETION; RECEPTORS, CELL SURFACE;

EID: 66549118068     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2008.10.011     Document Type: Review

References (98)

1. Newell-Price J., Bertagna X., Grossman A.B., et al. Cushing's syndrome. Lancet 367 (2006) 1605-1617
2. Lacroix A., Ndiaye N., Tremblay J., et al. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocrine Reviews 22 (2001) 75-110
3. Kirschner M.A., Powell Jr. R.D., and Lipsett M.B. Cushing's Syndrome: Nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor. The Journal of Clinical Endocrinology and Metabolism 24 (1964) 947-955
4. Lieberman S.A., Eccleshall T.R., and Feldman D. ACTH-independent massive bilateral adrenal disease (AIMBAD): a subtype of Cushing's syndrome with major diagnostic and therapeutic implications. European Journal of Endocrinology 131 (1994) 67-73
5. Stratakis C.A., and Kirschner L.S. Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Hormone and Metabolic Research 30 (1998) 456-463
6. Doppman J.L., Chrousos G.P., Papanicolaou D.A., et al. Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism. Radiology 216 (2000) 797-802
7. Swain J.M., Grant C.S., Schlinkert R.T., et al. Corticotropin-independent macronodular adrenal hyperplasia: a clinicopathologic correlation. Archives of Surgery 133 (1998) 541-546
8. Malchoff Cd M.D., and Malchoff D.M. Adrenocorticotropic hormone-independent adrenal hyperplasia. The Endocrinologist 6 (1996) 79-85
9. Kirk J.M., Brain C.E., Carson D.J., et al. Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. The Journal of Pediatrics 134 (1999) 789-792
10. Zeiger M.A., Nieman L.K., Cutler G.B., et al. Primary bilateral adrenocortical causes of Cushing's syndrome. Surgery 110 (1991) 1106-1115
11. Aiba M., Hirayama A., Iri H., et al. Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing's syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature. American Journal of Clinical Pathology 96 (1991) 334-340
12. Findlay J.C., Sheeler L.R., Engeland W.C., et al. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism 76 (1993) 189-191
13. Minami S., Sugihara H., Sato J., et al. ACTH independent Cushing's syndrome occurring in siblings. Clinical Endocrinology 44 (1996) 483-488
14. Nies C., Bartsch D.K., Ehlenz K., et al. Familial ACTH-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia clinically affecting only female family members. Experimental and Clinical Endocrinology & Diabetes 110 (2002) 277-283
15. Miyamura N., Taguchi T., Murata Y., et al. Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland. Endocrine 19 (2002) 319-326
16. Lee S., Hwang R., Lee J., et al. Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia. Clinical Endocrinology 63 (2005) 625-630
17. Vezzosi D., Cartier D., Regnier C., et al. Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. European Journal of Endocrinology 156 (2007) 21-31
18. Bourdeau I, Boisselle A, Rioux D, et al. Systematic Clinical Screening of Members of a Family with Hereditary Cortisol-Secreting B-Adrenergic Responsive ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH) Reveals Unsuspected Subclinical Cushing's Syndrome (CS) and Aberrant B-Adrenergic Regulation of Cortisol Secretion. Program of the 89th Annual Meeting of the Endocrine Society. Toronto, CA: 2007. p 148, Abstract OR54-2.
19. Skogseid B., Larsson C., Lindgren P.G., et al. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. The Journal of Clinical Endocrinology and Metabolism 75 (1992) 76-81
20. Burgess J.R., Harle R.A., Tucker P., et al. Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Archives of Surgery 131 (1996) 699-702
21. Yamakita N., Murai T., Ito Y., et al. Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas/carcinomas which showed a point mutation in the APC gene. Internal Medicine 36 (1997) 536-542
22. Marchesa P., Fazio V.W., Church J.M., et al. Adrenal masses in patients with familial adenomatous polyposis. Diseases of the Colon and Rectum 40 (1997) 1023-1028
23. Matyakhina L., Freedman R.J., Bourdeau I., et al. Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: a clinical and molecular genetic investigation. The Journal of Clinical Endocrinology and Metabolism 90 (2005) 3773-3779
24. Yamada Y., Sakaguchi K., Inoue T., et al. Preclinical Cushing's syndrome due to adrenocorticotropin-independent bilateral adrenocortical macronodular hyperplasia with concurrent excess of gluco- and mineralocorticoids. Internal Medicine 36 (1997) 628-632
25. Bourdeau I., D'Amour P., Hamet P., et al. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 5534-5540
26. Ohashi A., Yamada Y., Sakaguchi K., et al. A natural history of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) from preclinical to clinically overt Cushing's syndrome. Endocrine Journal 48 (2001) 677-683
27. Hayashi Y., Takeda Y., Kaneko K., et al. A case of Cushing's syndrome due to ACTH-independent bilateral macronodular hyperplasia associated with excessive secretion of mineralocorticoids. Endocrine Journal 45 (1998) 485-491
28. Malchoff C.D., Rosa J., DeBold C.R., et al. Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: an unusual cause of Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism 68 (1989) 855-860
29. Goodarzi M.O., Dawson D.W., Li X., et al. Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 73-77
30. Antonini S.R., Baldacchino V., Tremblay J., et al. Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome. Clinical Endocrinology 64 (2006) 29-36
31. Mircescu H., Jilwan J., N'Diaye N., et al. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 3531-3536
32. Hsiao HP, Verma S, Boikos SA, et al. A molecular and clinical genetic investigation of ACTH-independent macronodular adrenal hyperplasia compared to other, common adrenocortical tumors: evidence for heterogeneity, overlap with other tumor syndromes and frequent but atypical hormonal secretion. Program of the 89th Annual Meeting of the Endocrine Society. Toronto: 2007. p 403, Abstract P2-299.
33. Sasano H., Suzuki T., and Nagura H. ACTH-independent macronodular adrenocortical hyperplasia: immunohistochemical and in situ hybridization studies of steroidogenic enzymes. Modern Pathology 7 (1994) 215-219
34. Aiba M., Kawakami M., Ito Y., et al. Bilateral adrenocortical adenomas causing Cushing's syndrome. Report of two cases with enzyme histochemical and ultrastructural studies and a review of the literature. Archives of Pathology & Laboratory Medicine 116 (1992) 146-150
35. Doppman J.L., Nieman L.K., Travis W.D., et al. CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism. Journal of Computer Assisted Tomography 15 (1991) 773-779
36. Rockall A.G., Babar S.A., Sohaib S.A., et al. CT and MR imaging of the adrenal glands in ACTH-independent Cushing syndrome. Radiographics 24 (2004) 435-452
37. N'Diaye N., Hamet P., Tremblay J., et al. Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 2616-2622
38. Smals A.G., Pieters G.F., van Haelst U.J., et al. Macronodular adrenocortical hyperplasia in long-standing Cushing's disease. The Journal of Clinical Endocrinology and Metabolism 58 (1984) 25-31
39. Cugini P., Battisti P., Di Palma L., et al. 'GIANT' macronodular adrenal hyperplasia causing Cushing's syndrome: case report and review of the literature on a clinical distinction of adrenocortical nodular pathology associated with hypercortisolism. Endocrinologia Japonica 36 (1989) 101-116
40. Cheitlin R.A., Westphal M., Cabrera, et al. Cushing's syndrome due to bilateral adrenal macronodular hyperplasia with undetectable ACTH: cell culture of adenoma cells on extracellular matrix. Hormone Research 29 (1988) 162-167
41. Light K., Jenkins P.J., Weber A., et al. Are activating mutations of the adrenocorticotropin receptor involved in adrenal cortical neoplasia?. Life Sciences 56 (1995) 1523-1527
42. Latronico A.C., Reincke M., Mendonca B.B., et al. No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms. The Journal of Clinical Endocrinology and Metabolism 80 (1995) 875-877
43. Swords F.M., Baig A., Malchoff D.M., et al. Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity. Molecular Endocrinology 16 (2002) 2746-2753
44. Swords F.M., Noon L.A., King P.J., et al. Constitutive activation of the human ACTH receptor resulting from a synergistic interaction between two naturally occurring missence mutations in the MC2R gene. Molecular and Cellular Endocrinology 213 (2004) 149-154
45. Mauras N., and Blizzard R.M. The McCune-Albright syndrome. Acta Endocrinologica. Supplementum 279 (1986) 207-217
46. Aarskog D., and Tveteraas E. McCune-Albright's syndrome following adrenalectomy for Cushing's syndrome in infancy. The Journal of Pediatrics 73 (1968) 89-96
47. Benjamin D.R., and McRoberts J.W. Polyostotic fibrous dysplasia associated with Cushing syndrome. Archives of Pathology 96 (1973) 175-178
48. MacMahon H.E. Albright's syndrome-thirty years later. (Polyostotic fibrous dysplasia). Pathology Annual 6 (1971) 81-146
49. Danon M., Robboy S.J., Kim S., et al. Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancy. The Journal of Pediatrics 87 (1975) 917-921
50. Fragoso M.C., Domenice S., Latronico A.C., et al. Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 2147-2151
51. Lacroix A., Baldacchino V., Bourdeau I., et al. Cushing's syndrome variants secondary to aberrant hormone receptors. Trends in Endocrinology and Metabolism 15 (2004) 375-382
52. Bertagna X., Groussin L., Luton J.-P., et al. Aberrant receptor-mediated Cushing's syndrome. Hormone Research 59 Suppl. 1 (2003) 99-103
53. Schorr I., and Ney R.L. Abnormal hormone responses of an adrenocortical cancer adenyl cyclase. The Journal of Clinical Investigation 50 (1971) 1295-1300
54. Lacroix A., Bolte E., Tremblay J., et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion-a new cause of Cushing's syndrome. The New England Journal of Medicine 327 (1992) 974-980
55. Reznik Y., Allali-Zerah V., Chayvialle J.A., et al. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. The New England Journal of Medicine 327 (1992) 981-986
56. Lebrethon M.C., Avallet O., Reznik Y., et al. Food-dependent Cushing's syndrome: characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 4514-4519
57. Groussin L., Perlemoine K., Contesse V., et al. The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 1980-1985
58. Croughs R.J., Zelissen P.M., Van Vroonhoven Th.J., et al. GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH. Clinical Endocrinology 52 (2000) 235-240
59. Hamet P., Larochelle P., Franks D.J., et al. Cushing syndrome with food-dependent periodic hormonogenesis. Clinical and Investigative Medicine 10 (1987) 530-533
60. de Herder W.W., Hofland L.J., Usdin T.B., et al. Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells. The Journal of Clinical Endocrinology and Metabolism 81 (1996) 3168-3172
61. Chabre O., Liakos P., Vivier J., et al. Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 3134-3143
62. N'Diaye N., Tremblay J., Hamet P., et al. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 2781-2785
63. Tsagarakis S., Tsigos C., Vassiliou V., et al. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 583-589
64. Lampron A., Bourdeau I., Hamet P., et al. Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 3611-3618
65. Bertherat J., Contesse V., Louiset E., et al. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. The Journal of Clinical Endocrinology and Metabolism 90 (2005) 1302-1310
66. Swords F.M., Aylwin S., Perry L., et al. The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushing's disease?. The Journal of Clinical Endocrinology and Metabolism 90 (2005) 3009-3016
67. Baldacchino V., Oble S., Decarie P.O., et al. The Sp transcription factors are involved in the cellular expression of the human glucose-dependent insulinotropic polypeptide receptor gene and overexpressed in adrenals of patients with Cushing's syndrome. Journal of Molecular Endocrinology 35 (2005) 61-71
68. Mazzuco T.L., Chabre O., Sturm N., et al. Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model. Endocrinology 147 (2006) 782-790
69. Perraudin V., Delarue C., De Keyzer Y., et al. Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: in vivo and in vitro studies. The Journal of Clinical Endocrinology and Metabolism 80 (1995) 2661-2667
70. Horiba N., Suda T., Aiba M., et al. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism 80 (1995) 2336-2341
71. Iida K., Kaji H., Matsumoto H., et al. Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide. Clinical Endocrinology 47 (1997) 739-745
72. Lacroix A., Tremblay J., Touyz R.M., et al. Abnormal adrenal and vascular responses to vasopressin mediated by a V1- vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. The Journal of Clinical Endocrinology and Metabolism 82 (1997) 2414-2422
73. Daidoh H., Morita H., Hanafusa J., et al. In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia. Clinical Endocrinology 49 (1998) 403-409
74. Arnaldi G., Gasc J.M., de Keyzer Y., et al. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 2029-2035
75. Mune T., Murase H., Yamakita N., et al. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 5706-5713
76. Louiset E., Contesse V., Groussin L., et al. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates. The Journal of Endocrinology 196 (2008) 1-9
77. Lacroix A., Tremblay J., Rousseau G., et al. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. The New England Journal of Medicine 337 (1997) 1429-1434
78. Miyamura N., Tsutsumi A., Senokuchi H., et al. A case of ACTH-independent macronodular adrenal hyperplasia: simultaneous expression of several aberrant hormone receptors in the adrenal gland. Endocrine Journal 50 (2003) 333-340
79. Lacroix A., Hamet P., and Boutin J.M. Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. The New England Journal of Medicine 341 (1999) 1577-1581
80. Feelders R.A., Lamberts S.W., Hofland L.J., et al. Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 230-237
81. Cartier D., Lihrmann I., Parmentier F., et al. Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 248-254
82. Mannelli M., Ferruzzi P., Luciani P., et al. Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 4616-4622
83. Louiset E., Contesse V., Groussin L., et al. Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 4578-4586
84. Nakamura Y., Son Y., Kohno Y., et al. Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II. Endocrine 15 (2001) 57-61
85. Pralong F.P., Gomez F., Guillou L., et al. Food-dependent Cushing's syndrome: possible involvement of leptin in cortisol hypersecretion. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 3817-3822
86. Hashimoto K., Kawada Y., Murakami K., et al. Cortisol responsiveness to insulin-induced hypoglycemia in Cushing's syndrome with huge nodular adrenocortical hyperplasia. Endocrinologia Japonica 33 (1986) 479-487
87. Makino S., Hashimoto K., Sugiyama M., et al. Cushing's syndrome due to huge nodular adrenocortical hyperplasia with fluctuation of urinary 17-OHCS excretion. Endocrinologia Japonica 36 (1989) 655-663
88. Louisset E, Duparc, Groussin L, et al. Abnormal sensitivity of cortisol secretion to glucagon in primary adrenal Cushing's syndrome. Proceedings, XIII Adrenal cortex conference. San Francisco: June 11-14 2008. p 52, abstract 33.
89. Imohl M., Koditz R., Stachon A., et al. Catecholamine-dependent hereditary Cushing's syndrome - follow-up after unilateral adrenalectomy. Medizinische Klinik (Munich) 97 (2002) 747-753
90. Antonini S.R., N'Diaye N., Baldacchino V., et al. Analysis of the putative regulatory region of the gastric inhibitory polypeptide receptor gene in food-dependent Cushing's syndrome. The Journal of Steroid Biochemistry and Molecular Biology 91 (2004) 171-177
91. Bourdeau I., Antonini S.R., Lacroix A., et al. Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene 23 (2004) 1575-1585
92. Mazzuco T.L., Chabre O., Feige J.J., et al. Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 196-203
93. Bourdeau I., Matyakhina L., Stergiopoulos S.G., et al. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 3626-3632
94. Lefebvre H., Duparc C., Chartrel N., et al. Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 3035-3042
95. Lacroix A., Mircescu H., and Hamet P. Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing's syndrome. The Endocrinologist 9 (1999) 9-15
96. Reznik Y., Lefebvre H., Rohmer V., et al. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study. Clinical Endocrinology 61 (2004) 311-313
97. Boronat M., Lucas T., Barcelo B., et al. Cushing's syndrome due to autonomous macronodular adrenal hyperplasia: long-term follow-up after unilateral adrenalectomy. Postgraduate Medical Journal 72 (1996) 614-616
98. Lamas C., Alfaro J.J., Lucas T., et al. Is unilateral adrenalectomy an alternative treatment for ACTH-independent macronodular adrenal hyperplasia?: Long-term follow-up of four cases. European Journal of Endocrinology 146 (2002) 237-240